chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Acute myocardial infarction, Ejection fraction decreased
Clinical narrative: Narrative:  Pt hospitalized with STEMI and reduced EF, occurred 12 days following 3rd dose of Pfizer COVID vaccine. Patient admitted, therefore reporting to VADERS.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Haemorrhagic stroke
Clinical narrative: Narrative:  71yo mlae patient with Malignant neoplasm of larynx went to community ER on 10/20/21 with diagnosis of hemorragic stroke. Pt admitted to hospital and died at this hospital on 10/27/2021. Pt had received covid vaccine on 4/28/21 (J&J). This death is likely not related to the vaccinations due to comorbidities, age, and length of time from vaccine administration.
Age: 87.0
Sex: M
Vaccine: COVID19
Symptoms: Choking, Death, Resuscitation
Clinical narrative: Narrative:  86yo male died on 7/22/21 at community hospital (non-agency). His family reported that patient experienced a choking incident while eating lunch at his home on 7/22/21. Paid caregiver was present and attempted CPR. 911 called and patient "survived for about 20 hours" at hospital and passed. Pt had received covid vaccines on 1/20/21 & 2/22/21. This death is not related to covid vaccines.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Cardio-respiratory arrest, Death, Fall, Injury, Pneumothorax traumatic
Clinical narrative: Narrative:  70yo male patient fell 10-15 feet from his deer stand and was taken to non-agency trauma hospital. Pt coded in route to hospital arrived with traumatic pneumothorax. on 10/24/21. Pt died later on same day at same hospital. Death due to injuries from fall. Pt had received covid vaccines on 2/15/21 & 3/14/21. This death is not related to covid vaccines.
Age: 63.0
Sex: M
Vaccine: COVID19, FLUA4
Symptoms: Feeling cold, Tremor
Clinical narrative: Narrative: 63yr received Moderna COVID vaccine booster in one arm and Fluad vaccine in other arm on the same day. Seven hours later after receiving both vaccines patient reported to caregiver feeling of "shaking" and cold which lasted several minutes. No other sx of fever, CNS changes (ie seizures), or injection site reactions noted.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, COVID-19, Cough, Fatigue
Clinical narrative: Narrative: COVID infection following COVID vaccine series 12/29/2020, Pfizer, dose #1 01/19/2021, Pfizer, dose #2 10/08/2021, Pfizer, dose #3 08/18 pt cc: cough, fatigue, loss of taste or smell, exposure: unknown 09/16 COVID swab, result: detected 09/17 clinically resolved
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 12/29/2020, Pfizer, dose #1 01/19/2021, Pfizer, dose #2 10/08/2021, Pfizer, dose #3 08/18 pt cc: cough, fatigue, loss of taste or smell, exposure: unknown 09/16 COVID swab, result: detected 09/17 clinically resolved
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Anion gap, Anosmia, Blood bicarbonate decreased, Blood chloride decreased
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 04/22, Pfizer, dose #1 05/13, Pfizer, dose #2 09/15 pt cc: chills, cough, diarrhea, fatigue, headache, loss of taste or smell, myalgias, dyspnea, vomiting, exposure: unknown 09/16 ABG: i-pH 7.19, i-PCO2 26.1, i-P02 54, i-HCO3 9.9, 09/16 i-creatinine 1.3 09/16 i-BUN 37 09/16 i-glucose 648 09/16 i-chloride 94 09/16 i-anion gap 29 09/16 i-TCO2 10 09/18 i-Hemoglobin 18.4 09/16 i-Hematocrit 54 09/16 i-Sodium 127 09/16 i-Potassium 5.4 09/16 BinaxNOW COVID-19 Ag: deteted 09/16 SARS-COV-2 Variant Sequencing result: pending 09/16 COVID swab, result: detected 09/16 CXR impression: Extensive reticulonodular opacities within the mid and lower lung zones bilaterally, RIGHT slightly worse than LEFT, could reflect ongoing bronchiolitis among other etiologies. This might represent the inciting illness for the reported diabetic ketoacidosis. No focal pneumonia or pleural effusion. 09/16 pt admit ED cc: n/v dx: Acute COVID-19 infection complicated with pneumonitis/PNA with mild hypoxemia LOS: 2 days 09/16 lactic acid 2.76 09/17 FIBRINOGEN: 365 09/17 DDIMER: 1.26 09/17 ESR: 27 09/18 DDIMER: 1.55 09/27 clinically resolved
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Blood creatinine increased, Blood fibrinogen, Blood gases, Blood glucose increased, Blood lactic acid
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 04/22, Pfizer, dose #1 05/13, Pfizer, dose #2 09/15 pt cc: chills, cough, diarrhea, fatigue, headache, loss of taste or smell, myalgias, dyspnea, vomiting, exposure: unknown 09/16 ABG: i-pH 7.19, i-PCO2 26.1, i-P02 54, i-HCO3 9.9, 09/16 i-creatinine 1.3 09/16 i-BUN 37 09/16 i-glucose 648 09/16 i-chloride 94 09/16 i-anion gap 29 09/16 i-TCO2 10 09/18 i-Hemoglobin 18.4 09/16 i-Hematocrit 54 09/16 i-Sodium 127 09/16 i-Potassium 5.4 09/16 BinaxNOW COVID-19 Ag: deteted 09/16 SARS-COV-2 Variant Sequencing result: pending 09/16 COVID swab, result: detected 09/16 CXR impression: Extensive reticulonodular opacities within the mid and lower lung zones bilaterally, RIGHT slightly worse than LEFT, could reflect ongoing bronchiolitis among other etiologies. This might represent the inciting illness for the reported diabetic ketoacidosis. No focal pneumonia or pleural effusion. 09/16 pt admit ED cc: n/v dx: Acute COVID-19 infection complicated with pneumonitis/PNA with mild hypoxemia LOS: 2 days 09/16 lactic acid 2.76 09/17 FIBRINOGEN: 365 09/17 DDIMER: 1.26 09/17 ESR: 27 09/18 DDIMER: 1.55 09/27 clinically resolved
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Blood pH decreased, Blood potassium increased, Blood sodium decreased, Blood urea increased, COVID-19
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 04/22, Pfizer, dose #1 05/13, Pfizer, dose #2 09/15 pt cc: chills, cough, diarrhea, fatigue, headache, loss of taste or smell, myalgias, dyspnea, vomiting, exposure: unknown 09/16 ABG: i-pH 7.19, i-PCO2 26.1, i-P02 54, i-HCO3 9.9, 09/16 i-creatinine 1.3 09/16 i-BUN 37 09/16 i-glucose 648 09/16 i-chloride 94 09/16 i-anion gap 29 09/16 i-TCO2 10 09/18 i-Hemoglobin 18.4 09/16 i-Hematocrit 54 09/16 i-Sodium 127 09/16 i-Potassium 5.4 09/16 BinaxNOW COVID-19 Ag: deteted 09/16 SARS-COV-2 Variant Sequencing result: pending 09/16 COVID swab, result: detected 09/16 CXR impression: Extensive reticulonodular opacities within the mid and lower lung zones bilaterally, RIGHT slightly worse than LEFT, could reflect ongoing bronchiolitis among other etiologies. This might represent the inciting illness for the reported diabetic ketoacidosis. No focal pneumonia or pleural effusion. 09/16 pt admit ED cc: n/v dx: Acute COVID-19 infection complicated with pneumonitis/PNA with mild hypoxemia LOS: 2 days 09/16 lactic acid 2.76 09/17 FIBRINOGEN: 365 09/17 DDIMER: 1.26 09/17 ESR: 27 09/18 DDIMER: 1.55 09/27 clinically resolved
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Chest X-ray abnormal, Chills, Cough, Diabetic ketoacidosis, Diarrhoea
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 04/22, Pfizer, dose #1 05/13, Pfizer, dose #2 09/15 pt cc: chills, cough, diarrhea, fatigue, headache, loss of taste or smell, myalgias, dyspnea, vomiting, exposure: unknown 09/16 ABG: i-pH 7.19, i-PCO2 26.1, i-P02 54, i-HCO3 9.9, 09/16 i-creatinine 1.3 09/16 i-BUN 37 09/16 i-glucose 648 09/16 i-chloride 94 09/16 i-anion gap 29 09/16 i-TCO2 10 09/18 i-Hemoglobin 18.4 09/16 i-Hematocrit 54 09/16 i-Sodium 127 09/16 i-Potassium 5.4 09/16 BinaxNOW COVID-19 Ag: deteted 09/16 SARS-COV-2 Variant Sequencing result: pending 09/16 COVID swab, result: detected 09/16 CXR impression: Extensive reticulonodular opacities within the mid and lower lung zones bilaterally, RIGHT slightly worse than LEFT, could reflect ongoing bronchiolitis among other etiologies. This might represent the inciting illness for the reported diabetic ketoacidosis. No focal pneumonia or pleural effusion. 09/16 pt admit ED cc: n/v dx: Acute COVID-19 infection complicated with pneumonitis/PNA with mild hypoxemia LOS: 2 days 09/16 lactic acid 2.76 09/17 FIBRINOGEN: 365 09/17 DDIMER: 1.26 09/17 ESR: 27 09/18 DDIMER: 1.55 09/27 clinically resolved
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Fatigue, Fibrin D dimer, Haematocrit increased, Haemoglobin increased
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 04/22, Pfizer, dose #1 05/13, Pfizer, dose #2 09/15 pt cc: chills, cough, diarrhea, fatigue, headache, loss of taste or smell, myalgias, dyspnea, vomiting, exposure: unknown 09/16 ABG: i-pH 7.19, i-PCO2 26.1, i-P02 54, i-HCO3 9.9, 09/16 i-creatinine 1.3 09/16 i-BUN 37 09/16 i-glucose 648 09/16 i-chloride 94 09/16 i-anion gap 29 09/16 i-TCO2 10 09/18 i-Hemoglobin 18.4 09/16 i-Hematocrit 54 09/16 i-Sodium 127 09/16 i-Potassium 5.4 09/16 BinaxNOW COVID-19 Ag: deteted 09/16 SARS-COV-2 Variant Sequencing result: pending 09/16 COVID swab, result: detected 09/16 CXR impression: Extensive reticulonodular opacities within the mid and lower lung zones bilaterally, RIGHT slightly worse than LEFT, could reflect ongoing bronchiolitis among other etiologies. This might represent the inciting illness for the reported diabetic ketoacidosis. No focal pneumonia or pleural effusion. 09/16 pt admit ED cc: n/v dx: Acute COVID-19 infection complicated with pneumonitis/PNA with mild hypoxemia LOS: 2 days 09/16 lactic acid 2.76 09/17 FIBRINOGEN: 365 09/17 DDIMER: 1.26 09/17 ESR: 27 09/18 DDIMER: 1.55 09/27 clinically resolved
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Hypoxia, Lung opacity, Myalgia, Nausea
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 04/22, Pfizer, dose #1 05/13, Pfizer, dose #2 09/15 pt cc: chills, cough, diarrhea, fatigue, headache, loss of taste or smell, myalgias, dyspnea, vomiting, exposure: unknown 09/16 ABG: i-pH 7.19, i-PCO2 26.1, i-P02 54, i-HCO3 9.9, 09/16 i-creatinine 1.3 09/16 i-BUN 37 09/16 i-glucose 648 09/16 i-chloride 94 09/16 i-anion gap 29 09/16 i-TCO2 10 09/18 i-Hemoglobin 18.4 09/16 i-Hematocrit 54 09/16 i-Sodium 127 09/16 i-Potassium 5.4 09/16 BinaxNOW COVID-19 Ag: deteted 09/16 SARS-COV-2 Variant Sequencing result: pending 09/16 COVID swab, result: detected 09/16 CXR impression: Extensive reticulonodular opacities within the mid and lower lung zones bilaterally, RIGHT slightly worse than LEFT, could reflect ongoing bronchiolitis among other etiologies. This might represent the inciting illness for the reported diabetic ketoacidosis. No focal pneumonia or pleural effusion. 09/16 pt admit ED cc: n/v dx: Acute COVID-19 infection complicated with pneumonitis/PNA with mild hypoxemia LOS: 2 days 09/16 lactic acid 2.76 09/17 FIBRINOGEN: 365 09/17 DDIMER: 1.26 09/17 ESR: 27 09/18 DDIMER: 1.55 09/27 clinically resolved
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: PCO2 decreased, PO2 decreased, Pneumonia, Pneumonitis, Pulmonary mass
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 04/22, Pfizer, dose #1 05/13, Pfizer, dose #2 09/15 pt cc: chills, cough, diarrhea, fatigue, headache, loss of taste or smell, myalgias, dyspnea, vomiting, exposure: unknown 09/16 ABG: i-pH 7.19, i-PCO2 26.1, i-P02 54, i-HCO3 9.9, 09/16 i-creatinine 1.3 09/16 i-BUN 37 09/16 i-glucose 648 09/16 i-chloride 94 09/16 i-anion gap 29 09/16 i-TCO2 10 09/18 i-Hemoglobin 18.4 09/16 i-Hematocrit 54 09/16 i-Sodium 127 09/16 i-Potassium 5.4 09/16 BinaxNOW COVID-19 Ag: deteted 09/16 SARS-COV-2 Variant Sequencing result: pending 09/16 COVID swab, result: detected 09/16 CXR impression: Extensive reticulonodular opacities within the mid and lower lung zones bilaterally, RIGHT slightly worse than LEFT, could reflect ongoing bronchiolitis among other etiologies. This might represent the inciting illness for the reported diabetic ketoacidosis. No focal pneumonia or pleural effusion. 09/16 pt admit ED cc: n/v dx: Acute COVID-19 infection complicated with pneumonitis/PNA with mild hypoxemia LOS: 2 days 09/16 lactic acid 2.76 09/17 FIBRINOGEN: 365 09/17 DDIMER: 1.26 09/17 ESR: 27 09/18 DDIMER: 1.55 09/27 clinically resolved
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Red blood cell sedimentation rate increased, SARS-CoV-2 test, SARS-CoV-2 test positive, Vomiting
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 04/22, Pfizer, dose #1 05/13, Pfizer, dose #2 09/15 pt cc: chills, cough, diarrhea, fatigue, headache, loss of taste or smell, myalgias, dyspnea, vomiting, exposure: unknown 09/16 ABG: i-pH 7.19, i-PCO2 26.1, i-P02 54, i-HCO3 9.9, 09/16 i-creatinine 1.3 09/16 i-BUN 37 09/16 i-glucose 648 09/16 i-chloride 94 09/16 i-anion gap 29 09/16 i-TCO2 10 09/18 i-Hemoglobin 18.4 09/16 i-Hematocrit 54 09/16 i-Sodium 127 09/16 i-Potassium 5.4 09/16 BinaxNOW COVID-19 Ag: deteted 09/16 SARS-COV-2 Variant Sequencing result: pending 09/16 COVID swab, result: detected 09/16 CXR impression: Extensive reticulonodular opacities within the mid and lower lung zones bilaterally, RIGHT slightly worse than LEFT, could reflect ongoing bronchiolitis among other etiologies. This might represent the inciting illness for the reported diabetic ketoacidosis. No focal pneumonia or pleural effusion. 09/16 pt admit ED cc: n/v dx: Acute COVID-19 infection complicated with pneumonitis/PNA with mild hypoxemia LOS: 2 days 09/16 lactic acid 2.76 09/17 FIBRINOGEN: 365 09/17 DDIMER: 1.26 09/17 ESR: 27 09/18 DDIMER: 1.55 09/27 clinically resolved
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Headache, Myalgia, Pyrexia
Clinical narrative: Headache, Myalgia, Arthralgia, Fever, fatigue Narrative:
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 01/16, Pfizer, dose #1 02/06, Pfizer, dose #2 08/23 pt cc: no symptoms exposure: unknown 08/23 COVID swab, result: detected 09/03 COVID swab, result: not detected 09/13/ COVID swab, result: not detected
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Dyspnoea, Exposure to SARS-CoV-2, Fatigue
Clinical narrative: Narrative: COVID infection following COVID vaccine series 05/26 Janssen, dose #1 09/13 pt cc: cough, fatigue, headache, myalgias, rhinorrhea, dyspnea exposure: friend from chruch 09/15 COVID swab, result: detected 09/15 SARS-COV-2 Variant Sequencing result: pending 09/22 clinically resolved
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Myalgia, Rhinorrhoea, SARS-CoV-2 test, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 05/26 Janssen, dose #1 09/13 pt cc: cough, fatigue, headache, myalgias, rhinorrhea, dyspnea exposure: friend from chruch 09/15 COVID swab, result: detected 09/15 SARS-COV-2 Variant Sequencing result: pending 09/22 clinically resolved
Age: 38.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain upper, COVID-19, Dyspnoea, Myalgia, Oropharyngeal pain
Clinical narrative: Narrative: COVID infection following COVID vaccine series 03/19, Pfizer, dose #1 04/08, Pfizer, dose #2 08/12 pt cc: myalgias, rhinorrhea, congestion, dyspnea, sore throat exposure: unknown 08/17 COVID swab, result: detected 08/17 SARS-COV-2 Variant Sequencing result: pending 08/22 clinically resolved 09/10 pt admit to ED cc: stomach pain dx: LUQ abdominal pain LOS: 1 day
Age: 38.0
Sex: M
Vaccine: COVID19
Symptoms: Respiratory tract congestion, Rhinorrhoea, SARS-CoV-2 test, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 03/19, Pfizer, dose #1 04/08, Pfizer, dose #2 08/12 pt cc: myalgias, rhinorrhea, congestion, dyspnea, sore throat exposure: unknown 08/17 COVID swab, result: detected 08/17 SARS-COV-2 Variant Sequencing result: pending 08/22 clinically resolved 09/10 pt admit to ED cc: stomach pain dx: LUQ abdominal pain LOS: 1 day
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, COVID-19, Cough, Dyspnoea
Clinical narrative: Narrative: COVID infection following COVID vaccine series 04/13, Moderna dose #1 05/10, Moderna, dose #2 09/14 pt cc: cough, fatigue, loss of taste or smell, myalgias, dyspnea, headache, nausea, fever exposure: unknown 09/15 COVID swab, result: detected 09/15 SARS-COV-2 Variant Sequencing result: pending 09/24 clinically resolved
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache, Myalgia, Nausea, Pyrexia
Clinical narrative: Narrative: COVID infection following COVID vaccine series 04/13, Moderna dose #1 05/10, Moderna, dose #2 09/14 pt cc: cough, fatigue, loss of taste or smell, myalgias, dyspnea, headache, nausea, fever exposure: unknown 09/15 COVID swab, result: detected 09/15 SARS-COV-2 Variant Sequencing result: pending 09/24 clinically resolved
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 04/13, Moderna dose #1 05/10, Moderna, dose #2 09/14 pt cc: cough, fatigue, loss of taste or smell, myalgias, dyspnea, headache, nausea, fever exposure: unknown 09/15 COVID swab, result: detected 09/15 SARS-COV-2 Variant Sequencing result: pending 09/24 clinically resolved
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Exposure to SARS-CoV-2, Headache, Myalgia
Clinical narrative: Narrative: COVID infection following COVID vaccine series 01/27, Pfizer, dose #1 02/18, Pfizer, dose #2 07/13 COVID swab, result: NOT detected 09/14 COVID swab, result: detected 09/13 pt cc: cough, headache, myalgias, rhinorrhea, sore throat exposure: bother COVID + 09/23 clinically resolved
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Oropharyngeal pain, Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 01/27, Pfizer, dose #1 02/18, Pfizer, dose #2 07/13 COVID swab, result: NOT detected 09/14 COVID swab, result: detected 09/13 pt cc: cough, headache, myalgias, rhinorrhea, sore throat exposure: bother COVID + 09/23 clinically resolved
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Endocarditis
Clinical narrative: Narrative:  On 9/23/21 patient self-presented to community emergency facility. Chief complaint: Endocarditis, Stroke agency then informed pt died on 9/27/2021. Pt had received covid vaccines on 1/12/2021 and 8/23/2021- not local - not agency. Death not related to vaccines.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative:  79yo patient died on 9/24/2021. No info provided on pt's death. Pt had received covid vaccines on 2/14/21 & 3/13/21. Pt with med history of CAD, HF, AF CHADs2VASC 6 (age+2, TIA, HTN, CAD, DM), OSA, HTN, DM t2, History of esophageal strictures, & Remote History of TIA. Likely vaccines not related to pt's death given pt's age and length of time between date of vaccines given & date of pt's death.
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Cerebral mass effect, Computerised tomogram head abnormal, Condition aggravated, Craniotomy, Extradural haematoma
Clinical narrative: Narrative:  This is being reported as a SUSPECTED POSSIBLE ADR: 40 y/o m with epilepsy secondary to TBI (2014) who had a breakthrough seizure on 03/16/2021 and was admitted to sister hospital for post-ictal confusion. He was found to have L scalp fracture, R subdural and epidural hematomas with mass effect. CT head 03/16/21 (on admission): R temporal epidural hematoma measuring 1.1cm with mass effect, minimally displaced fracture of L orbital roof and foci of subarachnoid hemorrhage along with anterior falx. Pt had emergency craniotomy and evacuation or R subdural hematoma done on 03/16/21 and patient had uneventful post-operative course. Prior to this pt had been seizure free x 4 yrs and had received the Moderna vaccine 8 days earlier.
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Postictal state, Seizure, Skull fracture, Subarachnoid haemorrhage, Subdural haematoma
Clinical narrative: Narrative:  This is being reported as a SUSPECTED POSSIBLE ADR: 40 y/o m with epilepsy secondary to TBI (2014) who had a breakthrough seizure on 03/16/2021 and was admitted to sister hospital for post-ictal confusion. He was found to have L scalp fracture, R subdural and epidural hematomas with mass effect. CT head 03/16/21 (on admission): R temporal epidural hematoma measuring 1.1cm with mass effect, minimally displaced fracture of L orbital roof and foci of subarachnoid hemorrhage along with anterior falx. Pt had emergency craniotomy and evacuation or R subdural hematoma done on 03/16/21 and patient had uneventful post-operative course. Prior to this pt had been seizure free x 4 yrs and had received the Moderna vaccine 8 days earlier.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative:  73yo patient died on 10/21/21 after had self-presented to community emergency facility on 10/9/21. Pt was consult to cardiology and kidney on 10/20/21. No other info provided given about pt's death. Pt had received covid vaccines on 2/1/21 & 3/4/21. Likely vaccines not related to pt's death given pt's age and length of time between date of vaccines given & date of pt's death.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chills, Cough, Dyspnoea, Fatigue
Clinical narrative: Narrative: COVID infection following COVID vaccine series 03/27 Janssen, dose #1 09/12 pt cc: chills, cough, fatigue, fever, dyspnea, headache, exposure: unknown 09/14 COVID swab, result: detected 09/21 clinically resolved
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 03/27 Janssen, dose #1 09/12 pt cc: chills, cough, fatigue, fever, dyspnea, headache, exposure: unknown 09/14 COVID swab, result: detected 09/21 clinically resolved
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Asymptomatic COVID-19, Atelectasis, Chest X-ray normal, Computerised tomogram thorax abnormal, Pulmonary fibrosis
Clinical narrative: Narrative: COVID infection following COVID vaccine series 01/08, Pfizer, dose #1 01/29, Pfizer, dose #2 09/15 COVID swab, result: detected 09/15 pt cc: exposure; unknown 09/15 cc: dx: asymptomatic COVID-19 LOS: 2 DAYS 09/15 CXR impression: No acute cardiopulmonary disease. 09/16 CT chest impression: No acute focal airspace consolidation. Right basilar atelectasis/scarring.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 01/08, Pfizer, dose #1 01/29, Pfizer, dose #2 09/15 COVID swab, result: detected 09/15 pt cc: exposure; unknown 09/15 cc: dx: asymptomatic COVID-19 LOS: 2 DAYS 09/15 CXR impression: No acute cardiopulmonary disease. 09/16 CT chest impression: No acute focal airspace consolidation. Right basilar atelectasis/scarring.
Age: 26.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Oropharyngeal pain, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 05/11 Janssen, dose#1 09/10 pt cc: SORE THROAT exposure: unknown 09/15 COVID swab, result: detected
Age: 76.0
Sex: M
Vaccine: VARZOS
Symptoms: Incomplete course of vaccination, Rash, Refusal of vaccination
Clinical narrative: Narrative:  76 yo male candidate for Shingrix 2nd dose in series, refused on 9/21/21 after reporting rash after first dose administered on 7/30/21.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Fatigue, Headache, Myalgia
Clinical narrative: Narrative: COVID infection following COVID vaccine series 02/09, Pfizer, dose #11 03/02, Pfizer, dose #2 09/15 COVID swab, result: detected 09/07pt cc: cough, fatigue, myalgias, nausea, rhinorrhea, headache exposure: unknown 09/21 clinically resolved
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Nausea, Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 02/09, Pfizer, dose #11 03/02, Pfizer, dose #2 09/15 COVID swab, result: detected 09/07pt cc: cough, fatigue, myalgias, nausea, rhinorrhea, headache exposure: unknown 09/21 clinically resolved
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, COVID-19, Fatigue, Rhinorrhoea
Clinical narrative: Narrative: COVDI infection following COVID vaccine series 02/19, Pfizer, dose #1 03/12, Pfizer, dose #2 09/14 COVID swab, result: detected 09/14 pt cc: fatigue, loss of taste or smell, rhinorrhea exposure: unknown
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Narrative: COVDI infection following COVID vaccine series 02/19, Pfizer, dose #1 03/12, Pfizer, dose #2 09/14 COVID swab, result: detected 09/14 pt cc: fatigue, loss of taste or smell, rhinorrhea exposure: unknown
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Fatigue, SARS-CoV-2 test, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 03/10, MODERNA, dose #1 04/12, MODERNA, dose #2 09/15 COVID swab, result: detected 09/15 SARS-COV-2 Variant Sequencing result: pending 09/15 pt cc: fatigue exposure: unknown
Age: 78.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Acute kidney injury, COVID-19, COVID-19 pneumonia, Death, Diarrhoea
Clinical narrative: Narrative:  Patient presented to ER with progressive shortness of breath, fever, myalgias, change in taste, diarrhea, and positive COVID-19 test. He was symptomatic for the past 4 days or prior to ER presentation. Had a positive test at outside facility the day prior. Home oxygen saturation via self-monitoring and was low in the 80s so came to the ER for further evaluation. Progressive shortness of breath. Vaccinated for COVID with 2 doses earlier in the year. Dx with COVID PNA and admitted. PMH of CKD, HTN, HLD. Treated with dexamethasone (dexamethasone 6 mg tab 10/19-10/20), remdesivir (200mg IV once 10/19), supplemental O2, albuterol/ipratropium inhalers, zinc, vit C, vit D, and PRN benzonatate, guaifenesin, codeine/guaifenesin, and throat lozenges. Transferred to MICU 10/19/21. Treated with barictinib (2mg doses 10/19-10/20). Intubated 10/20. Complications included septic shock, pre-renal AKI, and hypocalcemia. Patient died 10/21/21.
Age: 78.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Dyspnoea, Endotracheal intubation, Hypocalcaemia, Intensive care, Myalgia
Clinical narrative: Narrative:  Patient presented to ER with progressive shortness of breath, fever, myalgias, change in taste, diarrhea, and positive COVID-19 test. He was symptomatic for the past 4 days or prior to ER presentation. Had a positive test at outside facility the day prior. Home oxygen saturation via self-monitoring and was low in the 80s so came to the ER for further evaluation. Progressive shortness of breath. Vaccinated for COVID with 2 doses earlier in the year. Dx with COVID PNA and admitted. PMH of CKD, HTN, HLD. Treated with dexamethasone (dexamethasone 6 mg tab 10/19-10/20), remdesivir (200mg IV once 10/19), supplemental O2, albuterol/ipratropium inhalers, zinc, vit C, vit D, and PRN benzonatate, guaifenesin, codeine/guaifenesin, and throat lozenges. Transferred to MICU 10/19/21. Treated with barictinib (2mg doses 10/19-10/20). Intubated 10/20. Complications included septic shock, pre-renal AKI, and hypocalcemia. Patient died 10/21/21.
Age: 78.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Oxygen saturation decreased, Pyrexia, SARS-CoV-2 test positive, Septic shock, Taste disorder
Clinical narrative: Narrative:  Patient presented to ER with progressive shortness of breath, fever, myalgias, change in taste, diarrhea, and positive COVID-19 test. He was symptomatic for the past 4 days or prior to ER presentation. Had a positive test at outside facility the day prior. Home oxygen saturation via self-monitoring and was low in the 80s so came to the ER for further evaluation. Progressive shortness of breath. Vaccinated for COVID with 2 doses earlier in the year. Dx with COVID PNA and admitted. PMH of CKD, HTN, HLD. Treated with dexamethasone (dexamethasone 6 mg tab 10/19-10/20), remdesivir (200mg IV once 10/19), supplemental O2, albuterol/ipratropium inhalers, zinc, vit C, vit D, and PRN benzonatate, guaifenesin, codeine/guaifenesin, and throat lozenges. Transferred to MICU 10/19/21. Treated with barictinib (2mg doses 10/19-10/20). Intubated 10/20. Complications included septic shock, pre-renal AKI, and hypocalcemia. Patient died 10/21/21.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough, Diarrhoea, Exposure to SARS-CoV-2, Rhinorrhoea
Clinical narrative: Narrative: COVID infection following COVID vaccine series *04/03, Pfizer, dose #1 (non-Facility) 04/24, Pfizer, dose #2 (non-Facility) 09/16 COVID swab, result: detected 09/15 pt cc: cough, diarrhea, rhinorrhea exposure: husband
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series *04/03, Pfizer, dose #1 (non-Facility) 04/24, Pfizer, dose #2 (non-Facility) 09/16 COVID swab, result: detected 09/15 pt cc: cough, diarrhea, rhinorrhea exposure: husband
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Diarrhoea, Oropharyngeal pain, Rhinorrhoea
Clinical narrative: Narrative: COVID infection following COVID vaccine series 01/04, Pfizer, dose #1 01/25, Pfizer, dose #2 10/20, Pfizer, dose #3 09/14 COVID swab, result: detected 09/16 pt cc: cough, diarrhea, rhinorrhea, sore throat exposure: unknown
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 01/04, Pfizer, dose #1 01/25, Pfizer, dose #2 10/20, Pfizer, dose #3 09/14 COVID swab, result: detected 09/16 pt cc: cough, diarrhea, rhinorrhea, sore throat exposure: unknown
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, COVID-19, Cough, Diarrhoea
Clinical narrative: Narrative: Covid infection following COVID vaccine series 02/03, Pfizer, dose #1 02/23, Pfizer, dose #2 09/13 COVID swab, result: detected 09/10 pt cc: cough, diarrhea, fatigue, loss of taste or smell, myalgias, nausea, rhinorrhea, vomiting exposure: unknown 09/13 SARS-COV-2 Variant Sequencing result: pending 09/21 clinically resolved
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Myalgia, Nausea, Rhinorrhoea, SARS-CoV-2 test
Clinical narrative: Narrative: Covid infection following COVID vaccine series 02/03, Pfizer, dose #1 02/23, Pfizer, dose #2 09/13 COVID swab, result: detected 09/10 pt cc: cough, diarrhea, fatigue, loss of taste or smell, myalgias, nausea, rhinorrhea, vomiting exposure: unknown 09/13 SARS-COV-2 Variant Sequencing result: pending 09/21 clinically resolved
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Vomiting
Clinical narrative: Narrative: Covid infection following COVID vaccine series 02/03, Pfizer, dose #1 02/23, Pfizer, dose #2 09/13 COVID swab, result: detected 09/10 pt cc: cough, diarrhea, fatigue, loss of taste or smell, myalgias, nausea, rhinorrhea, vomiting exposure: unknown 09/13 SARS-COV-2 Variant Sequencing result: pending 09/21 clinically resolved
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Red blood cell sedimentation rate increased, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 04/13, MODERNA, dose #1 05/28, MODERNA, dose #2 09/14 pt cc: exposure: unknown 09/14 COVID swab, result: detected 10/19 ESR: 31
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, COVID-19, Cough, Diarrhoea
Clinical narrative: Narrative: COVID infection following COVID vaccine series 01/15, Pfizer, dose #1 02/01, Pfizer, dose #2 09/14 COVID swab, result: detected 09/08 pt cc: cough, fatigue, nausea, loss of taste or smell, myalgias, diarrhea, cough exposure: unknown 09/22 clinically resolved 10/28 COVID swab, result: not detected
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Myalgia, Nausea, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 01/15, Pfizer, dose #1 02/01, Pfizer, dose #2 09/14 COVID swab, result: detected 09/08 pt cc: cough, fatigue, nausea, loss of taste or smell, myalgias, diarrhea, cough exposure: unknown 09/22 clinically resolved 10/28 COVID swab, result: not detected
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chills, Cough, Diarrhoea, Headache
Clinical narrative: Narrative: COVID infection following COVID vaccine series 01/04, Pfizer, dose #1 01/25, Pfizer, dose #2 09/13 COVID swab, result: detected 09/8 pt cc: chills, cough, diarrhea, fever, headache, myalgias, sinus congestion, sore throat, exposure: unknown
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Oropharyngeal pain, Pyrexia, SARS-CoV-2 test positive, Sinus congestion
Clinical narrative: Narrative: COVID infection following COVID vaccine series 01/04, Pfizer, dose #1 01/25, Pfizer, dose #2 09/13 COVID swab, result: detected 09/8 pt cc: chills, cough, diarrhea, fever, headache, myalgias, sinus congestion, sore throat, exposure: unknown
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, COVID-19, Cough, Diarrhoea
Clinical narrative: Narrative: COVID infection following COVID vaccine series 06/16, MODERNA, dose #1 07/14, MODERNA, dose# 2 09/13 COVID swab, result: detected 09/13 SARS-COV-2 Variant Sequencing result: pending 09/22 COVID swab, result: detected 09/12 pt cc: cough, fever, loss of taste or smell, myalgias, diarrhea exposure; unknown 09/21 clinically resolved
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Pyrexia, SARS-CoV-2 test, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 06/16, MODERNA, dose #1 07/14, MODERNA, dose# 2 09/13 COVID swab, result: detected 09/13 SARS-COV-2 Variant Sequencing result: pending 09/22 COVID swab, result: detected 09/12 pt cc: cough, fever, loss of taste or smell, myalgias, diarrhea exposure; unknown 09/21 clinically resolved
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Blood fibrinogen normal, COVID-19, Chest X-ray abnormal, Cough, Fatigue
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 04/06, Pfizer, dose #1 04/27, Pfizer, dose #2 09/14 COVID swab, result: detected 09/11 pt cc: fatigue exposure: unknown 09/14 CXR impression Pulmonary vascular crowding due to the expiratory technique. Superimposed bibasilar interstitial pulmonary opacities as seen in viral pneumonia are not excluded. 09/14 pt admit to ED cc: cough dx: Hyperglycemic state likely secondary to acute covid-19 infection and 2. COVID-19 complicated with pneumonia and mild hypoxemia LOS: 4 09/18 FIBRINOGEN: 267 09/18 DDIMER: <0.22 09/18 CXR impression: Interval development of patchy right greater than left airspace opacity. 09/22 clinically resolved
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Fibrin D dimer, Hyperglycaemia, Hypoxia, Lung opacity, Pneumonia
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 04/06, Pfizer, dose #1 04/27, Pfizer, dose #2 09/14 COVID swab, result: detected 09/11 pt cc: fatigue exposure: unknown 09/14 CXR impression Pulmonary vascular crowding due to the expiratory technique. Superimposed bibasilar interstitial pulmonary opacities as seen in viral pneumonia are not excluded. 09/14 pt admit to ED cc: cough dx: Hyperglycemic state likely secondary to acute covid-19 infection and 2. COVID-19 complicated with pneumonia and mild hypoxemia LOS: 4 09/18 FIBRINOGEN: 267 09/18 DDIMER: <0.22 09/18 CXR impression: Interval development of patchy right greater than left airspace opacity. 09/22 clinically resolved
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Pulmonary vascular disorder, SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 04/06, Pfizer, dose #1 04/27, Pfizer, dose #2 09/14 COVID swab, result: detected 09/11 pt cc: fatigue exposure: unknown 09/14 CXR impression Pulmonary vascular crowding due to the expiratory technique. Superimposed bibasilar interstitial pulmonary opacities as seen in viral pneumonia are not excluded. 09/14 pt admit to ED cc: cough dx: Hyperglycemic state likely secondary to acute covid-19 infection and 2. COVID-19 complicated with pneumonia and mild hypoxemia LOS: 4 09/18 FIBRINOGEN: 267 09/18 DDIMER: <0.22 09/18 CXR impression: Interval development of patchy right greater than left airspace opacity. 09/22 clinically resolved
Age: 36.0
Sex: M
Vaccine: COVID19
Symptoms: Asthma, Bronchial hyperreactivity, COVID-19, Condition aggravated, Cough
Clinical narrative: Narrative: COVID infection following COVID vaccine series 03/17, Pfizer, dose #1 04/07, Pfizer, dose #2 07/15 COVID swab, result: not detected 09/15 COVID swab, result: detected 09/15 BinaxNOW COVID-19 Ag result: not detected\ 09/15 SARS-COV-2 Variant Sequencing result: pending 09/15 PROCALCITONI: <0.05 09/15 pt admit to ED cc: cough, st, body aches, fever x 4 days dx: COVID 19 infection /Mild to moderate illness/No pneumonia/Normal oxygenation Asthma exacerbation/reactive airways LOS: 1 day 09/11 pt cc: exposure: unknown
Age: 36.0
Sex: M
Vaccine: COVID19
Symptoms: Pain, Procalcitonin, Pyrexia, SARS-CoV-2 test, SARS-CoV-2 test negative
Clinical narrative: Narrative: COVID infection following COVID vaccine series 03/17, Pfizer, dose #1 04/07, Pfizer, dose #2 07/15 COVID swab, result: not detected 09/15 COVID swab, result: detected 09/15 BinaxNOW COVID-19 Ag result: not detected\ 09/15 SARS-COV-2 Variant Sequencing result: pending 09/15 PROCALCITONI: <0.05 09/15 pt admit to ED cc: cough, st, body aches, fever x 4 days dx: COVID 19 infection /Mild to moderate illness/No pneumonia/Normal oxygenation Asthma exacerbation/reactive airways LOS: 1 day 09/11 pt cc: exposure: unknown
Age: 36.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 03/17, Pfizer, dose #1 04/07, Pfizer, dose #2 07/15 COVID swab, result: not detected 09/15 COVID swab, result: detected 09/15 BinaxNOW COVID-19 Ag result: not detected\ 09/15 SARS-COV-2 Variant Sequencing result: pending 09/15 PROCALCITONI: <0.05 09/15 pt admit to ED cc: cough, st, body aches, fever x 4 days dx: COVID 19 infection /Mild to moderate illness/No pneumonia/Normal oxygenation Asthma exacerbation/reactive airways LOS: 1 day 09/11 pt cc: exposure: unknown
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Sensation of foreign body, Throat irritation, Throat tightness
Clinical narrative: Narrative: Patient received 1st dose of COVID-19 Pfizer vaccine and developed a "lump" in her throat that was mildly itchy and tight. Refused to go to ED after 3x and was observed for 1 hour. Took Benadryl when she arrived home and slept and later said she is feeling better.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Exposure to SARS-CoV-2, Fatigue, Oropharyngeal pain, Rhinorrhoea
Clinical narrative: Narrative: COVD infection following COVID vaccine series 02/09, Pfizer, dose #1 03/02, Pfizer, dose #2 08/03 pt cc: fatigue, rhinorrhea, sore throat exposure, daughter in school 08/18 COVID swab, result: detected 08/18 SARS-COV-2 Variant Sequencing result: pending
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVD infection following COVID vaccine series 02/09, Pfizer, dose #1 03/02, Pfizer, dose #2 08/03 pt cc: fatigue, rhinorrhea, sore throat exposure, daughter in school 08/18 COVID swab, result: detected 08/18 SARS-COV-2 Variant Sequencing result: pending
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, No adverse event
Clinical narrative: Narrative: Patient received 1st and 2nd doses of Moderna Covid Vaccines on March 16 and April 13, 2021. Patients Covid Vaccine booster wasn't due until October 13, 2021 IF his first doses of the vaccine had been the Pfizer Covid Vaccine. However, patient came to clinic on 9/27/2021 and was administered a Pfizer booster dose of the vaccine. Patient is not immunocompromised. No adverse event was noted to have occurred as the result of this error.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, COVID-19, Cough, Fatigue
Clinical narrative: Narrative: COVID infection following COVID vaccine series 04/12, Pfizer, dose #1 05/03, Pfizer, dose #2 08/17 pt cc: cough., fatigue, headache, fever, rhinorrhea, loss of taste or smell exposure: unknown 08/18 COVID swab, result: detected 08/18 SARS-COV-2 Variant Sequencing result: pending.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Pyrexia, Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 04/12, Pfizer, dose #1 05/03, Pfizer, dose #2 08/17 pt cc: cough., fatigue, headache, fever, rhinorrhea, loss of taste or smell exposure: unknown 08/18 COVID swab, result: detected 08/18 SARS-COV-2 Variant Sequencing result: pending.
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 01/13, MODERNA, dose #1 02/10, MODERNA, dose #2 08/17 pt cc: rhinorrhea exposure: unknown 08/18 COVID swab, result: detected
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection FOLLOWIN COVID vaccine series 01/27, Pfizer, dose #1 02/17 , Pfizer, dose #2 08/18 pt cc: exposure: unknown 08/18 COVID swab, result: detected
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chest X-ray abnormal, Dyspnoea, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 03/19, Pfizer, dose #1 07/16, Pfizer, dose #2 05/20 CXR impression: 1. Stable chesrt with probable persistent air trapping. 07/27 COVID-19 SCR Eval: not detected 08/18 COVID swab, result: detected 08/19 pt cc: dyspnea exposure; unknown 08/31 COVID-19 SCR Eval: not detected
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Chest pain, Dizziness, Fatigue, Feeling abnormal
Clinical narrative: Narrative: Patient received Pfizer dose #1 08/20/21 and developed left-sided chest pain/tightness, as well as brain fog/fatigue/dizziness. She had onset of symptoms about 3 days she received the Pfizer Covid19 vaccination and they persisted for weeks including when she went to the ER 09/09/21 for evaluation. She had benign findings about 10day s/p PFIZER #1 with no therapeutic intervention required. Patient had minimal/no symptoms with PFIZER #2 in SEPT 2021. Notable, patient was diagnosed with COVID-19 several months prior to vaccination.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Malaise
Clinical narrative: Narrative: Patient received Pfizer dose #1 08/20/21 and developed left-sided chest pain/tightness, as well as brain fog/fatigue/dizziness. She had onset of symptoms about 3 days she received the Pfizer Covid19 vaccination and they persisted for weeks including when she went to the ER 09/09/21 for evaluation. She had benign findings about 10day s/p PFIZER #1 with no therapeutic intervention required. Patient had minimal/no symptoms with PFIZER #2 in SEPT 2021. Notable, patient was diagnosed with COVID-19 several months prior to vaccination.
Age: 36.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Diarrhoea, Fatigue, Headache, Pyrexia
Clinical narrative: Narrative: COVID infection following COVID vaccine series 03/02, Moderna, dose #1 03/29 Moderna , dose #2 08/18 pt cc: diarrhea, fatigue, fever, headache, rhinorrhea exposure: unknown 08/20 COVID swab, result: detected
Age: 36.0
Sex: M
Vaccine: COVID19
Symptoms: Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 03/02, Moderna, dose #1 03/29 Moderna , dose #2 08/18 pt cc: diarrhea, fatigue, fever, headache, rhinorrhea exposure: unknown 08/20 COVID swab, result: detected
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: Narrative: Patient received her second COVID vaccine on 3/30/21 and per notes on 4/1/21 she went to a non facility with c/o hives. NO scanned records from that facility are available. Reaction was not reported ot the facility until 10/4/21. She received her first vaccine on 3/2/21 and had no reported reactions. No prior history of reaction to an vaccines per records. No documentation of what treatments, if any, were given to treat her hives.
Age: 68.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Acute respiratory failure, COVID-19, COVID-19 pneumonia, Cough, Deep vein thrombosis
Clinical narrative: Narrative:  Presented to the ER on 8/2. Completed full COVID vaccine series in March 2021. PMH significant for CAD, HFpEF, HLD, atrial fibrillation (on rivaroxaban), DM2, Crohn's disease, bipolar disorder, and obesity. He started feeling ill 6 days prior to ER visit and presented with worsening symptoms of cough with greenish sputum, SOB, and fever. Diagnosed with COVID pneumonia and hypoxic respiratory failure and admitted. Treated with dexamethasone, remdesivir, supplemental oxygen, and supportive care. Discharged on 8/9 with dexamethasone course. Presented to the ED again on 8/13 due to worsening SOB, persistent non-productive cough, and O2 sat 86%. Admitted to ICU with acute hypoxic respiratory failure secondary to new submassive bilateral PEs and bilateral DVTs (suspected to be provoked coagulopathy s/p COVID infection). Progressive respiratory failure requiring intubation 8/19 (13 day duration) for superimposed pneumonia with septic shock. Discharged on 9/14 to skilled nursing facility for rehab while still on oxygen.
Age: 68.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Dyspnoea, Endotracheal intubation, Intensive care, Malaise, Productive cough
Clinical narrative: Narrative:  Presented to the ER on 8/2. Completed full COVID vaccine series in March 2021. PMH significant for CAD, HFpEF, HLD, atrial fibrillation (on rivaroxaban), DM2, Crohn's disease, bipolar disorder, and obesity. He started feeling ill 6 days prior to ER visit and presented with worsening symptoms of cough with greenish sputum, SOB, and fever. Diagnosed with COVID pneumonia and hypoxic respiratory failure and admitted. Treated with dexamethasone, remdesivir, supplemental oxygen, and supportive care. Discharged on 8/9 with dexamethasone course. Presented to the ED again on 8/13 due to worsening SOB, persistent non-productive cough, and O2 sat 86%. Admitted to ICU with acute hypoxic respiratory failure secondary to new submassive bilateral PEs and bilateral DVTs (suspected to be provoked coagulopathy s/p COVID infection). Progressive respiratory failure requiring intubation 8/19 (13 day duration) for superimposed pneumonia with septic shock. Discharged on 9/14 to skilled nursing facility for rehab while still on oxygen.
Age: 68.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pulmonary embolism, Pyrexia, SARS-CoV-2 test positive, Septic shock, Sputum discoloured
Clinical narrative: Narrative:  Presented to the ER on 8/2. Completed full COVID vaccine series in March 2021. PMH significant for CAD, HFpEF, HLD, atrial fibrillation (on rivaroxaban), DM2, Crohn's disease, bipolar disorder, and obesity. He started feeling ill 6 days prior to ER visit and presented with worsening symptoms of cough with greenish sputum, SOB, and fever. Diagnosed with COVID pneumonia and hypoxic respiratory failure and admitted. Treated with dexamethasone, remdesivir, supplemental oxygen, and supportive care. Discharged on 8/9 with dexamethasone course. Presented to the ED again on 8/13 due to worsening SOB, persistent non-productive cough, and O2 sat 86%. Admitted to ICU with acute hypoxic respiratory failure secondary to new submassive bilateral PEs and bilateral DVTs (suspected to be provoked coagulopathy s/p COVID infection). Progressive respiratory failure requiring intubation 8/19 (13 day duration) for superimposed pneumonia with septic shock. Discharged on 9/14 to skilled nursing facility for rehab while still on oxygen.